Evaluation of gene mutation status and metastasis in lung adenocarcinoma: a multicentric prospective study in Turkey

S. Yilmaz (Eskisehir, Turkey), S. Metintas (Eskisehir, Turkey), M. Karadag (Bursa, Turkey), N. Yilmaz Demirci (Ankara, Turkey), O. Aydin Guclu (Bursa, Turkey), P. Akin Kabalak (Ankara, Turkey), U. Yilmaz (Ankara, Turkey), G. Ak (Eskisehir, Turkey), D. Kizilgöz (Ankara, Turkey), A. Ozturk (Istanbul, Turkey), U. Yilmaz (Izmir, Turkey), O. Batum (Izmir, Turkey), M. Kavas (Istanbul, Turkey), I. Serifoglu (Ankara, Turkey), M. Unsal (Samsun, Turkey), B. E. Komurcuoglu (Izmir, Turkey), T. Inal Cengiz (Ankara, Turkey), G. Ulubay (Ankara, Turkey), T. S. Ozdemirel (Ankara, Turkey), B. A.Ozyurek (Ankara, Turkey), S. Kavurgaci (Ankara, Turkey), D. Alizoroglu (Izmir, Turkey), P. Celik (Izmir, Turkey), Y. Erdogan (Ankara, Turkey), A. Zamani (Konya, Turkey), E. In (Elazig, Turkey), A. Aksoy (Elazig, Turkey), S. Altin (Istanbul, Turkey), G. Gunluoglu (Istanbul, Turkey), M. Metintas (Eskisehir, Turkey)

Source: International Congress 2019 – Biology and prognosis of lung cancer
Session: Biology and prognosis of lung cancer
Session type: Thematic Poster
Number: 3052
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Yilmaz (Eskisehir, Turkey), S. Metintas (Eskisehir, Turkey), M. Karadag (Bursa, Turkey), N. Yilmaz Demirci (Ankara, Turkey), O. Aydin Guclu (Bursa, Turkey), P. Akin Kabalak (Ankara, Turkey), U. Yilmaz (Ankara, Turkey), G. Ak (Eskisehir, Turkey), D. Kizilgöz (Ankara, Turkey), A. Ozturk (Istanbul, Turkey), U. Yilmaz (Izmir, Turkey), O. Batum (Izmir, Turkey), M. Kavas (Istanbul, Turkey), I. Serifoglu (Ankara, Turkey), M. Unsal (Samsun, Turkey), B. E. Komurcuoglu (Izmir, Turkey), T. Inal Cengiz (Ankara, Turkey), G. Ulubay (Ankara, Turkey), T. S. Ozdemirel (Ankara, Turkey), B. A.Ozyurek (Ankara, Turkey), S. Kavurgaci (Ankara, Turkey), D. Alizoroglu (Izmir, Turkey), P. Celik (Izmir, Turkey), Y. Erdogan (Ankara, Turkey), A. Zamani (Konya, Turkey), E. In (Elazig, Turkey), A. Aksoy (Elazig, Turkey), S. Altin (Istanbul, Turkey), G. Gunluoglu (Istanbul, Turkey), M. Metintas (Eskisehir, Turkey). Evaluation of gene mutation status and metastasis in lung adenocarcinoma: a multicentric prospective study in Turkey. 3052

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study
Source: Eur Respir J, 50 (6) 1701493; 10.1183/13993003.01493-2017
Year: 2017



Mutational status of advanced lung adenocarcinoma in a Portuguese cohort
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019

Prospective population-based study on the survival of patients with lung cancer
Source: Eur Respir J 2002; 19: 1087-1092
Year: 2002



Early symptoms in suspected lung cancer: a prospective cohort study
Source: Eur Respir J 2001; 18: Suppl. 33, 64s
Year: 2001

Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study
Source: ERJ Open Res, 6 (4) 00061-2020; 10.1183/23120541.00061-2020
Year: 2020



Occupational lung cancer: a multicentric case-control study in Paris area
Source: Annual Congress 2009 - Occupational exposures and disease I
Year: 2009

TNM and survival in small cell lung cancer: results of a population-based study
Source: Eur Respir J 2001; 18: Suppl. 33, 394s
Year: 2001

Population-based study of synchronous primary malignant lung tumours
Source: Breathe 2008; 4: 368
Year: 2008

Retrospective study of treatment outcomes according to exon difference with EGFR mutations in non-small cell lung cancer patient in Korea
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012


Cost-effectiveness analysis of three strategies of erlotinib treatment in non small-cell lung cancer: A prospective multicentric French study (ERMETIC)
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

Pemetrexed in the first line treatment in non-small cell lung cancer (NSCLC): A multicentre prospective analysis of data from clinical practise of Czech Republic
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012


Natural course of asymptomatic malignant pleural effusion in non-small-cell lung cancer patients: a multicenter retrospective study
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020

Prognostic value of symptoms at lung cancer diagnosis: a two-year observational study
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019

Determinants of the performance status in stage IV nonsmall cell lung cancer - results of a population-based study
Source: Eur Respir J 2001; 18: Suppl. 33, 230s
Year: 2001

Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: a multicentric retrospective cohort study
Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
Year: 2020




Synchronous lung cancer and solitary brain metastasis in the elderly: an outcome study
Source: Eur Respir J 2006; 28: Suppl. 50, 126s
Year: 2006

Comparative analysis of the results of surgical treatment for pulmonary metastases from colorectal cancer and metastases from other primary origin
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016

Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010

Bronchial colonisation in patients with lung cancer: a prospective study
Source: Eur Respir J 2013; 42: 220-229
Year: 2013



A case study of oligometastatic lung adenocarcinoma
Source: International Congress 2015 – Lung cancer: the need for a multidisciplinary approach - an interactive session
Year: 2015